Mechanisms of DNA breaks induction in vivo by 5-azacytidine: paths of micronucleus induction by azaC
✍ Scribed by P. Morales-Ramírez; T. Vallarino-Kelly; V. L. Cruz-Vallejo
- Book ID
- 102293877
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 200 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0260-437X
- DOI
- 10.1002/jat.1274
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The aim of the present study was to correlate the time‐response curves of micronucleated polychromatic erythrocyte (MN‐PCE) induction by 5‐azacytidine (azaC) with the possible processes involved in DNA break production; this is based on the results previously published by other authors. The MN‐PCE induction at two different doses of azaC was determined by sampling blood from the tails of mice before the acute treatment and over nine periods of 8 h each afterwards. Both doses caused two peaks of MN‐PCE induction, one at 32 h and another at 48 h, approximately; a shoulder was detected that remained high from 56 h up to the end of the study (72 h). These results suggest that azaC induced DNA breaks and subsequently MN (micronucleus) by three different mechanisms, and in agreement with data in the literature, these could be successively the following: (i) during excision of the large adduct comprising the DNA methyl transferase covalently linked to DNA; (ii) failure of recombination repair or mismatch repair; and (iii) persistent chromosome fragility in G‐C rich sites due to DNA demethylation and chromatin decondensation. Copyright © 2007 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
In vitro exposure of normal human diploid fibroblasts (strain VH-10) to ethylene oxide (EtO) induced DNA strand breaks in the dose range of 2.5-30 mMh of EtO. Alkaline DNA unwinding (ADU), neutral filter elution (NFE), pulsed field gel electrophoresis (PFGE), and the comet assay were used to measure
## Abstract Certain genes, termed oncogenes, have the ability to transmit the transformed phenotype from tumor cells to hitherto normal cells in vitro and in vivo. This observation is the basis for the concern that medicinal products derived from tumor cell lines could contain possibly tumorigenic